Skip to main content

Table 1 Price to the public published in the Official Gazette and net of the compulsory discounts provided by law

From: Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region

COMBINATION

EX-FACTORY PRICE

PRICE TO THE PUBLIC

FF/UMEC/VI

€ 48.90*

€ 80.70*

BDP/FOR/GB

€ 55.54**

€ 91.67**

  1. Abbreviations: FF: fluticasone furoate; UMEC: umeclidinium; VI: vilanterol; BDP: beclomethasone dipropionate; FOR: formoterol fumarate; GB: glycopyrronium bromide. Notes: Prices are to be intended net of the two cuts provided by Italian law. *GU n°58 of 09/03/2019; **GU n.1859 of December 20, 2019
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us